ABN AMRO Investment Solutions’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $414K | Buy |
5,296
+34
| +0.6% | +$2.66K | 0.01% | 360 |
|
|
2025
Q1 | $381K | Sell |
5,262
-35,773
| -87% | -$2.59M | 0.01% | 353 |
|
|
2024
Q4 | $3.04M | Buy |
41,035
+2,135
| +5% | +$158K | 0.06% | 211 |
|
|
2024
Q3 | $2.57M | Buy |
38,900
+32,430
| +501% | +$2.14M | 0.04% | 234 |
|
|
2024
Q2 | $598K | Buy |
6,470
+3,697
| +133% | +$341K | 0.01% | 378 |
|
|
2024
Q1 | $265K | Hold |
2,773
| – | – | ﹤0.01% | 397 |
|
|
2023
Q4 | $211K | Buy |
+2,773
| New | +$211K | ﹤0.01% | 413 |
|
|
2023
Q3 | – | Sell |
-2,179
| Closed | -$206K | – | 416 |
|
|
2023
Q2 | $206K | Buy |
+2,179
| New | +$206K | ﹤0.01% | 401 |
|